Since elevated activity of the GH/IGF-I pathway has been implicated in specific types of cancer, the low levels of IGF-I found in GHR−/− mice and LS patients, along with their insensitivity to GH, may be important for their relative lack of cancer [125–128]. Here, GHR is linked to Leigh syndrome.